Table 2. Oxidative stress markers, cytokines, and Lp-PLA2 activity according to menopausal status.
Premenopausal women (n = 96) | Postmenopausal women (n = 80) | P0 | P1 | |||||
Plasma oxidized LDL(U/L)∮ | 40.9 | ± | 11.4 | 56.7 | ± | 23.8 | <0.001 | 0.031 |
Urinary 8-epi-PGF2α (pg/mg creatinine)∮ | 1079.1 | ± | 281.6 | 1199.8 | ± | 461.5 | 0.179 | 0.400 |
Serum IL-6 (pg/mL)∮ | 1.94 | ± | 1.28 | 4.53 | ± | 5.27 | <0.001 | 0.005 |
Serum TNF-α (pg/mL)∮ | 5.88 | ± | 7.03 | 6.64 | ± | 10.6 | 0.795 | 0.213 |
Serum IL-1ß (pg/mL)∮ | 0.70 | ± | 1.17 | 0.77 | ± | 1.53 | 0.929 | 0.961 |
Lp-PLA2 activity (nmol/mL/min) | 28.3 | ± | 9.42 | 30.6 | ± | 7.77 | 0.084 | 0.447 |
Nonstimulated PBMC | ||||||||
IL-6 (pg/mL)∮ | 786.1 | ± | 3107.9 | 1409.0 | ± | 6504.8 | <0.001 | 0.027 |
TNF-α (pg/mL)∮ | 169.3 | ± | 803.4 | 626.9 | ± | 2044.3 | <0.001 | 0.008 |
IL-1ß (pg/mL)∮ | 14.4 | ± | 42.4 | 119.7 | ± | 351.2 | <0.001 | <0.001 |
Lp-PLA2 activity (nmol/mL/min) | 2.01 | ± | 0.55 | 2.11 | ± | 0.61 | 0.265 | 0.621 |
Mean ± SD. Tested by independent t-test or general linear model with the adjustment.
tested by log-transformed. P0: unadjusted, P1: adjusted for age, BMI and alcohol consumption.